Abeona Therapeutics (ABEO) Tops Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ABEO Hot Sheet
Join SI Premium – FREE
Abeona Therapeutics (NASDAQ: ABEO) reported Q3 EPS of ($0.48), $0.05 better than the analyst estimate of ($0.53).
For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chime Financial, Inc. (CHYM) Tops Q3 EPS by 13c ; Offers Guidance
- biote Corp. (BTMD) Misses Q3 EPS by 1c ; Offers Guidance
- Universal Corp. (UVV) Misses Q2 EPS by 83c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
